Clinical Development of Targeted Fragile X Syndrome Treatments: An Industry Perspective

Abstract excerpt

) gene, resulting in a deficit of fragile X mental retardation protein (FMRP). The clinical presentation of FXS is variable, and is typically associated with developmental delays, intellectual disability, a wide range of behavioral issues, and certain identifying physical features. Over the past 25 years, researchers have worked to understand the complex relationship between FMRP deficiency and the symptoms of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Autism Spectrum Disorder Research
• Share to Genetics and Neurodevelopmental Disorders
• Share to Pancreatic function and diabetes